Phenoxymethylpenicillin 125mg/5ml oral solution

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Phenoxymethylpenicillin potassium

から入手可能:

Kent Pharma (UK) Ltd

ATCコード:

J01CE02

INN（国際名）:

Phenoxymethylpenicillin potassium

投薬量:

25mg/1ml

医薬品形態:

Oral solution

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 05010101; GTIN: 5015201009184

製品の特徴

OBJECT 1
PHENOXYMETHYLPENICILLIN 125 MG/5ML ORAL
SOLUTION
Summary of Product Characteristics Updated 24-Aug-2017 | Kent
Pharmaceuticals Ltd
1. Name of the medicinal product
Phenoxymethylpenicillin 125 mg/5ml Oral Solution or Tenkicin 125
mg/5ml Oral Solution
2. Qualitative and quantitative composition
Each 5ml of Oral Solution contains 125mg of Phenoxymethylpenicillin as
Phenoxymethylpenicillin
Potassium Ph.Eur.
3. Pharmaceutical form
Powder for oral solution
4. Clinical particulars
4.1 Therapeutic indications
Phenoxymethylpenicillin and phenoxymethylpenicillin potassium are
indicated in the treatment of mild to
moderately severe infections associated with micro-organisms whose
susceptibility to penicillin is within
the range of serum levels attained with the dosage form.
Phenoxymethylpenicillin is indicated for prophylaxis against:
• Pneumococcol infection (e.g. in asplenia and in patients with
sickle cell disease).
Note: Severe empyema, bacteraemia, pericarditis, meningitis and
arthritis should not be treated with
Penicillin V during the acute phase.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
The following infections will usually respond to adequate doses:
Streptococcal infections (without bacteraemia): Mild to moderate
infections of the upper respiratory tract,
scarlet fever and mild erysipelas.
Pneumococcal infections: mild to moderately severe infections of the
respiratory tract. Staphylococcal
infections sensitive to penicillin: mild infections of the skin and
soft tissues. Fusospirochaetosis
(Vincent's gingivitis and pharyngitis): mild to moderately severe
infections of the oropharynx usually
respond to therapy with oral penicillin.
Prophylactic use: prophylaxis with oral penicillin has proved
effective in preventing recurrence of
rheumatic fever and chorea.
Patients with a past history of rheumatic fever receiving continuous
prophylaxis may harbour penicillin-
resistant organisms. In these patients, the use of another
prophylactic agent should be c